Prostate-specific Antigen–Based Prostate Cancer Screening: Reduction of Prostate Cancer Mortality After Correction for Nonattendance and Contamination in the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer-Reference-Cited by-同舟云学术

Prostate-specific Antigen–Based Prostate Cancer Screening: Reduction of Prostate Cancer Mortality After Correction for Nonattendance and Contamination in the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer

Published:2014-02 Issue:2 Volume:65 Page:329-336
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Bokhorst Leonard P.,Bangma Chris H.,van Leenders Geert J.L.H.,Lous Jan J.,Moss Sue M.,Schröder Fritz H.,Roobol Monique J.

Publisher

Elsevier BV

Subject

Urology

Reference26 articles.

1. Screening for prostate cancer: results of the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer;Roobol;Eur Urol,2013

2. Adjusting for non-compliance and contamination in randomized clinical trials;Cuzick;Stat Med,1997

3. Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC);Roobol;Eur Urol,2009

4. European Randomized Study of Screening for Prostate Cancer (ERSPC): rationale, structure and preliminary results;Roobol;BJU Int,2003

5. Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, The Netherlands);Roobol;BJU Int,2003

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate Cancer Early Detection in the European Union and UK;European Urology;2024-08

2. Randomized trials of PSA screening;Urologic Oncology: Seminars and Original Investigations;2024-06

3. Established and emerging liquid biomarkers for prostate cancer detection: A review;Urologic Oncology: Seminars and Original Investigations;2024-06

4. Prostate-Specific Antigen-Based Prostate Cancer Screening: One for All or Individualized for Each Race? – A Narrative Review;Journal of Urologic Oncology;2024-03-31

5. Mortality reduction and cumulative excess incidence (CEI) in the prostate-specific antigen (PSA) screening era;Scientific Reports;2024-03-09